BOSTON, May 3 – Harvard’s Institute of Proteomics will seek to raise $100 million from private and public sources in a bid to develop a repository of full-length cDNA clones that would assist researchers in their efforts to study proteins, Joshua LaBaer, the director of the institute, said Thursday.

“Celera and a number of other companies are planning to do proteomics profiling. We’re looking to be able to produce proteins rather than study them,” said LaBaer following a talk at the Whitehead Institute for Biomedical Research. “We’d like to give everybody access to the clones.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.